Results 101 to 110 of about 1,199,024 (153)

Activation of Sigma 1 Receptor Preserves Visual Function After Optic Nerve Injury. [PDF]

Invest Ophthalmol Vis Sci
Wang J, Xu Z, Caldwell R.
europepmc   +1 more source

Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders. [PDF]

Pharmaceuticals (Basel)
Eskandari K, Bélanger SM, Lachance V, Kourrich S.   +3 more
europepmc   +1 more source

Sigma-1 receptor counteracts non-cell-autonomous poly-PR-induced astrocytic oxidative stress in C9orf72 ALS. [PDF]

Redox Biol
Wu HC, Huang TW, Weng EF, Lin CY, Su TP, Wu HE, Wang SM.   +6 more
europepmc   +1 more source

A Full-Spectrum Evaluation of Sigma-1 Receptor (S1R) Positron Emission Tomography (PET) Radioligands from Binding Affinity to Clinical Imaging. [PDF]

Molecules
Mastropasqua F, Ludwig FA, Abate C.
europepmc   +1 more source

The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease. [PDF]

CNS Drugs
Goldberg YP, Navon-Perry L, Cruz-Herranz A, Chen K, Hecker-Barth G, Spiegel K, Cohen Y, Niethammer M, Tan AM, Schuring H, Geva M, Hayden MR.   +11 more
europepmc   +1 more source

Identification of peripheral pain generators with sigma-1 receptor Positron Emission Tomography/Magnetic Resonance Imaging in complex regional pain syndrome: initial study in a prospective trial. [PDF]

Pain
Baal JD, Ghimire P, Wagle S, Lewis M, Xu Y, Tawfik VL, Davidzon G, McCurdy CR, Biswal S, Yoon D.   +9 more
europepmc   +1 more source

Positive Protective Effects of Sigma-1 Receptor Stimulation with Fluvoxamine after Myocardial Ischemia and Reperfusion in Rats. [PDF]

Mol Imaging Biol
Zhang X, Wakabayashi H, Mori H, Hiromasa T, Chen Z, Kozaka T, Ogawa K, Kinuya S, Taki J.   +8 more
europepmc   +1 more source

Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders. [PDF]

ACS Pharmacol Transl Sci
Shokr MM, Badawi GA, Elshazly SM, Zaki HF, Mohamed AF.   +4 more
europepmc   +1 more source

Sigma-1 Receptor Activation by Fluvoxamine Ameliorates ER Stress, Synaptic Dysfunction and Behavioral Deficits in a Ketamine Model of Schizophrenia. [PDF]

J Neuroimmune Pharmacol
Ahmed MK, Abdou K, Ibrahim WW, Mohamed AF, El-Boghdady NA.   +4 more
europepmc   +1 more source

Longitudinal <i>in vivo</i> (<i>R</i>)-[¹⁸F]FBFP PET imaging for preclinical evaluation of cerebral sigma-1 receptor after ischemic stroke. [PDF]

Theranostics
Yang J, Liu L, Zhou H, Huang C, Wang D, Wang Z, Shi Y, Song S, Deng X, Zhu Y, Zhao J, Tang Z, Jia H, Zhu X.   +13 more
europepmc   +1 more source